When did BAUDAX BIO INC (BXRX) report earnings last quarter?
BAUDAX BIO INC (BXRX) last reported earnings on 11/14/2023.
BAUDAX BIO INC (BXRX) Earnings History & Surprises
NASDAQ:BXRX • US07160F4046
Current stock price
0.1864 USD
+0 (+0.59%)
At close:
0.17 USD
-0.02 (-8.8%)
After Hours:
BXRX Earnings overview
Past quarterly earnings results for BAUDAX BIO INC (BXRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Feb 21, 2024
- Period
- Q3 / 2023
- EPS Estimate
- -$0.54
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 14, 2023
- Period
- Q2 / 2023
- EPS Reported
- -$1.52
- EPS Surprise
- 26.95%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | -1.52 | -2.08 | 26.95% | 96.38% | - | - | ||
| Q1 2023 | -3.91 | 5.87 | -166.67% | 96.92% | - | - | ||
| Q4 2022 | -12.33 | -9.96 | -23.85% | -103.07% | 310K | - | -22.50% | |
| Q3 2022 | -26.40 | -21.62 | -22.09% | 90.57% | 240K | 984.3K | -75.62% | -14.29% |
| Q2 2022 | -42.00 | -51.82 | 18.94% | 86.96% | 788.46K | -100.00% | -100.00% | |
| Q1 2022 | -126.80 | -75.48 | -67.99% | 66.46% | 568.14K | -100.00% | -100.00% | |
| Q4 2021 | 401.20 | 60.18 | 566.67% | 152.10% | 400K | 637.5K | -37.25% | 400.00% |
| Q3 2021 | -280.00 | -221.34 | -26.50% | -132.26% | 280K | 612K | -54.25% | 300.00% |
| Q2 2021 | -322.00 | -285.60 | -12.75% | 86.63% | 200K | 476.003K | -57.98% | -42.86% |
| Q1 2021 | -378.00 | -276.08 | -36.92% | 93.02% | 200K | 645.997K | -69.04% | - |
| Q4 2020 | -770.00 | -866.32 | 11.12% | - | 80K | 1.666M | -95.20% | - |
| Q3 2020 | 868.00 | -1,051.96 | 182.51% | - | 70K | 1.02M | -93.14% | - |
| Q2 2020 | -2,408.00 | -932.96 | -158.10% | - | 350K | 135.997K | 157.36% | - |
| Q1 2020 | -5,418.00 | -2,551.36 | -112.36% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-46.41%
Max EPS beat (4)
26.95%
Min EPS beat (4)
-166.67%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, BXRX has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, BXRX reported -46.4% below the EPS estimates on average.
Related analysis
BAUDAX BIO INC / BXRX Earnings FAQ
Did BXRX stock beat earnings estimates in the most recent quarter?
BAUDAX BIO INC (BXRX) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often BAUDAX BIO INC beats earnings estimates?
In the last 4 quarters, BAUDAX BIO INC (BXRX) has beaten EPS estimates in 1 out of 4 releases.